ClinicalTrials.Veeva

Menu

Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.

F

Federal Teaching Hospital Abakaliki

Status and phase

Completed
Phase 2
Phase 1

Conditions

Postpartum Anaemia

Treatments

Drug: oral iron
Drug: intravenous iron

Study type

Interventional

Funder types

Other

Identifiers

NCT07110935
FMC/QEH/G.596/Vol.10/266

Details and patient eligibility

About

Background:Anaemia is a condition of public health importance.Iron deficiency anaemia is the most common cause of anaemia in pregnancy.Postpartum anaemia poses a significant role for postpartum morbidity and mortality and should be treated.Postpartum iron deficiency anaemia warrants greater attention and higher quality of care.Oral iron treatment has been considered the standard of care.

However,parenteral iron treatment is expected to be advantageous in cases where oral iron therapy is not possible.As a result,there is increased interest in parenteral iron therapy.

Objectives:To determine the effect of treatment of postpartum anaemia with intravenous versus oral iron therapy at Federal Medical Centre,Umuahia.

Materials and Method:This study is a prospective randomized controlled study carried out in department of Obstetric and Gynaecology, Federal Medical Centre,Umuahia,the capital of Abia State,South-east, Nigeria. The study population comprised of postpartum women with mild to moderate anaemia within 48 hours of delivery who were randomized into two groups.One group will be given oral iron therapy and the other intravenous iron dextran.Response and comparative effects of treatment using either route of administration were assessed at 6 weeks postpartum.The biodata,obstetric characteristics and haemoglobin estimation of the respondents were recorded on a structured study proforma.The data obtained from the study was analyzed with the statistical package for the social sciences(SPSS) software.Continuous variables obtained from this study were expressed as mean and standard deviation while categorical variables were summarized using frequency and percentages.Association between categorical variables were done using chi square.P-value less than 0.05 was taken as significant.

Enrollment

290 patients

Sex

Female

Ages

20 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women who have vaginal delivery of singleton baby and are seen within 48hours of childbirth
  • Women with mild and moderate anaemia
  • Women who gave their consent to participate in the study.

Exclusion criteria

  • Women with severe anaemia
  • Women with multiple pregnancy
  • Women with genotype HbSS
  • Women with HIV infection
  • Women who delivered by caesarean section
  • Women with co-morbidity like hypertensive disorders, renal pathology
  • Women who decline consent after adequate counseling.
  • Previous and current history of adverse reaction to iron dextran

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

290 participants in 2 patient groups

One hundred and forty five women who picked "i" were assigned intravenous iron therapy group
Experimental group
Treatment:
Drug: intravenous iron
One hundred and forty five women who picked "o" were assigned oral iron therapy group
Active Comparator group
Treatment:
Drug: oral iron

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems